Cargando…

Non-invasive characterization of human bone marrow stimulation and reconstitution by cell-free messenger RNA sequencing

Circulating cell-free mRNA (cf-mRNA) holds great promise as a non-invasive diagnostic biomarker. However, cf-mRNA composition and its potential clinical applications remain largely unexplored. Here we show, using Next Generation Sequencing-based profiling, that cf-mRNA is enriched in transcripts der...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibarra, Arkaitz, Zhuang, Jiali, Zhao, Yue, Salathia, Neeraj S., Huang, Vera, Acosta, Alexander D., Aballi, Jonathan, Toden, Shusuke, Karns, Amy P., Purnajo, Intan, Parks, Julianna R., Guo, Lucy, Mason, James, Sigal, Darren, Nova, Tina S., Quake, Stephen R., Nerenberg, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972916/
https://www.ncbi.nlm.nih.gov/pubmed/31964864
http://dx.doi.org/10.1038/s41467-019-14253-4
Descripción
Sumario:Circulating cell-free mRNA (cf-mRNA) holds great promise as a non-invasive diagnostic biomarker. However, cf-mRNA composition and its potential clinical applications remain largely unexplored. Here we show, using Next Generation Sequencing-based profiling, that cf-mRNA is enriched in transcripts derived from the bone marrow compared to circulating cells. Further, longitudinal studies involving bone marrow ablation followed by hematopoietic stem cell transplantation in multiple myeloma and acute myeloid leukemia patients indicate that cf-mRNA levels reflect the transcriptional activity of bone marrow-resident hematopoietic lineages during bone marrow reconstitution. Mechanistically, stimulation of specific bone marrow cell populations in vivo using growth factor pharmacotherapy show that cf-mRNA reflects dynamic functional changes over time associated with cellular activity. Our results shed light on the biology of the circulating transcriptome and highlight the potential utility of cf-mRNA to non-invasively monitor bone marrow involved pathologies.